Differences Between Women With COVID-19 and Long Covid

University of Valencia

Status: Completed

Conditions: COVID-19

Treatments: Diagnostic Test: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT05669235

OBS_LCOVID

Details and patient eligibility

About

The coronavirus disease of 2019 (COVID-19) has infected more than 630 million people and resulted in more than 6.5 million deaths worldwide. Among the possible sequelae of the virus, a disorder called long COVID has shown to affect about 10% of those infected, mostly adult women, without comorbidities.

Long COVID corresponds to a multisystemic syndrome following the acute period of the disease, in which the person maintains persistent symptoms such as fatigue, dyspnea, cough, memory loss, muscle and joint pain, among others.

Now that time has passed, it is necessary to verify why there are women who present symptoms of long covid and others do not.

Enrollment: 23 patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women between 18 and 65 years
• That they have passed COVID-19 at least once.
• Whether or not they have symptoms secondary to COVID-19.

Exclusion criteria

• They do not want to sign the informed consent.

Trial design

23 participants in 2 patient groups

Long covid

Description:

Women who present symptoms after suffering from COVID-19, consistent with long covid.

Treatment:

Diagnostic Test: Questionnaires

Covid

Description:

Women who have passed COVID-19 without consequences.

Treatment:

Diagnostic Test: Questionnaires